MTHFR 677C→T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease
- 1 August 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 350 (9078) , 603-604
- https://doi.org/10.1016/s0140-6736(05)63320-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Disorders of homocysteine metabolismJournal of Inherited Metabolic Disease, 1997
- Thermolabile variant of 5, 10-methylenetetrahydrofolate reductaseassociated with low red-cell folates: implications for folate intake recommendationsThe Lancet, 1997
- Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysisQJM: An International Journal of Medicine, 1997
- Methylenetetrahydrofolate Reductase Gene and Coronary Artery DiseaseCirculation, 1997
- Methylenetetrahydrofolate Reductase Polymorphism, Plasma Folate, Homocysteine, and Risk of Myocardial Infarction in US PhysiciansCirculation, 1996
- Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C 677 T MutationArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATIONThe Lancet, 1980